WonderBrain Technologies
Early-stage Diagnostic Solution for Common Brain Disorders and Diseases
Company Overview
Snapshot
Founded in January 2022 by Yehonatan Roth, Adam Beck, and Nahum Cohen, WonderBrain Technologies operated with 1–10 employees. The company focused on developing diagnostic solutions for common brain disorders and diseases. In July 2023, WonderBrain Technologies ceased operations.
Business overview
WonderBrain Technologies developed a stationary medical device designed for the early detection and diagnosis of common brain diseases such as Parkinson's, dementia, and Alzheimer's. The patented solution integrated innovative engineering, automation, and AI-driven software, leveraging two years of medical research and successful clinical trials. Operating within the Health Tech & Life Sciences sector, specifically in Medical Devices and Diagnostics Devices, the company aimed to provide an affordable, accessible, non-invasive, and rapid diagnostic solution for healthcare providers globally, particularly in North America and Europe.
Log in to access full profile ›Company Intelligence Q&A
- What is the primary focus of WonderBrain Technologies?
- WonderBrain Technologies focused on developing an early-stage diagnostic solution for common brain disorders and diseases, including Parkinson's, dementia, and Alzheimer's disease.
- When was WonderBrain Technologies founded?
- WonderBrain Technologies was founded in January 2022.
- Who are the founders of WonderBrain Technologies?
- The company was founded by Yehonatan Roth, Adam Beck, and Nahum Cohen.
- What is the status of WonderBrain Technologies?
- WonderBrain Technologies is currently non-active, having ceased operations in July 2023.
- What technology does WonderBrain Technologies utilize in its diagnostic solution?
- The company's patented diagnostic solution combines innovative engineering concepts, automation, and AI-driven software for early detection of brain disorders.